Free Trial

Arcus Biosciences (RCUS) SEC Filings & 10K Form

$15.72
-0.43 (-2.66%)
(As of 04:20 PM ET)

Recent Arcus Biosciences SEC Filings

DateFilerForm TypeView
08/27/2024
3:12 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
3:45 PM
Arcus Biosciences (Issuer)
Azoy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:53 PM
Arcus Biosciences (Issuer)
Tang Carolyn C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:54 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:54 PM
Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:54 PM
Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:19 PM
Arcus Biosciences (Issuer)
Lambert Nicole (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:20 PM
Arcus Biosciences (Issuer)
Ribas Antoni (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:20 PM
Arcus Biosciences (Issuer)
PERLMAN ANDREW J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:20 PM
Arcus Biosciences (Issuer)
Machado Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:20 PM
Arcus Biosciences (Issuer)
FALBERG KATHRYN E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:20 PM
Arcus Biosciences (Issuer)
Lacey David L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
5:21 PM
Arcus Biosciences (Issuer)
KANEKO YASUNORI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2024
3:28 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2024
7:18 AM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/23/2024
3:59 PM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2024
7:21 PM
Arcus Biosciences (Filer)
Form ARS
04/23/2024
3:08 PM
Arcus Biosciences (Filer)
Form DEF 14A
04/23/2024
3:10 PM
Arcus Biosciences (Filer)
Form DEFA14A
03/29/2024
3:20 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2024
3:19 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
3:30 PM
Arcus Biosciences (Subject)
Jarrett Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2024
6:55 PM
Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:55 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
4:49 PM
Arcus Biosciences (Issuer)
Goeltz II Robert C. (Reporting)
Form 4/A
02/21/2024
3:53 PM
Arcus Biosciences (Filer)
Form S-3ASR
02/21/2024
3:16 PM
Arcus Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/09/2024
7:35 AM
Arcus Biosciences (Subject)
FMR LLC (Filed by)
Form SC 13G
02/07/2024
5:58 PM
Arcus Biosciences (Issuer)
Mercier Johanna (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/31/2024
3:58 PM
Arcus Biosciences (Subject)
GILEAD SCIENCES, INC. (Filed by)
Form SC 13D/A
01/31/2024
4:00 PM
Arcus Biosciences (Issuer)
GILEAD SCIENCES, INC. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
7:17 AM
Arcus Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2024
6:38 PM
Arcus Biosciences (Issuer)
Nuyten Dimitry SA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:39 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:39 PM
Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:39 PM
Arcus Biosciences (Issuer)
Tang Carolyn C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:39 PM
Arcus Biosciences (Issuer)
Azoy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:40 PM
Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
6:40 PM
Arcus Biosciences (Issuer)
Goeltz II Robert C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
6:33 AM
Arcus Biosciences (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
01/23/2024
10:52 AM
Arcus Biosciences (Subject)
Form SC 13G/A
Apple to take the AI industry by storm on September 10 (Ad)

Apple is often late to embrace new technologies, yet they almost always go on to crush their competition... But I believe they're finally set to roll out their first ever AI device by September 10...

01/04/2024
4:22 PM
Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
4:23 PM
Arcus Biosciences (Issuer)
Goeltz II Robert C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
4:44 PM
Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
4:47 PM
Arcus Biosciences (Subject)
Goeltz II Robert C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2024
4:17 PM
Arcus Biosciences (Subject)
Jaen Juan C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/22/2023
3:20 PM
Arcus Biosciences (Subject)
Jarrett Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/22/2023
3:06 PM
Arcus Biosciences (Issuer)
Azoy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:09 PM
Arcus Biosciences (Issuer)
ROSEN TERRY J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:09 PM
Arcus Biosciences (Issuer)
Jaen Juan C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:09 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:10 PM
Arcus Biosciences (Issuer)
Goeltz II Robert C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:10 PM
Arcus Biosciences (Issuer)
Azoy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:10 PM
Arcus Biosciences (Issuer)
Nuyten Dimitry SA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:10 PM
Arcus Biosciences (Issuer)
Tang Carolyn C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
3:28 PM
Arcus Biosciences (Issuer)
Azoy Alexander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/26/2023
3:35 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/22/2023
3:16 PM
Arcus Biosciences (Subject)
Jarrett Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/20/2023
3:46 PM
Arcus Biosciences (Issuer)
Jarrett Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2023
3:47 PM
Arcus Biosciences (Issuer)
Nuyten Dimitry SA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2023
3:53 PM
Arcus Biosciences (Subject)
Nuyten Dimitry SA (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/15/2023
3:49 PM
Arcus Biosciences (Subject)
Jarrett Jennifer (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NYSE:RCUS) was last updated on 9/6/2024 by MarketBeat.com Staff

From Our Partners